Oncorus
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
FLYNN JAMES E director, 10 percent owner, oth..
 Common Stock 166,442 $9.5 $1,581,199
Option
ASHBURN THEODORE director, officer: President an..
 Common Stock 1,900 N/A N/A
Option
ASHBURN THEODORE director, officer: President an..
 Employee Stock Option (right to buy) 1,900 N/A N/A
Purchase
GADICKE ANSBERT 10 percent owner
 Common Stock 325,000 $15 $4,875,000
Purchase
FLYNN JAMES E director, 10 percent owner, oth..
 Common Stock 554,806 $15 $8,322,090
Purchase
FLYNN JAMES E director, 10 percent owner, oth..
 Common Stock 554,806 N/A N/A
Purchase
UBS ONCOLOGY IMPACT FUND L.P. 10 percent owner
 Common Stock 151,224 $15 $2,268,360
Purchase
GADICKE ANSBERT 10 percent owner
 Common Stock 325,000 $15 $4,875,000
Purchase
MPM BIOVENTURES 2014, L.P. 10 percent owner
 Common Stock 173,776 $15 $2,606,640
Purchase
MPM SUNSTATES FUND, L.P. 10 percent owner
 Common Stock 173,776 N/A N/A
Purchase
EVNIN LUKE director, 10 percent owner
 Common Stock 151,225 $15 $2,268,375

Showing 50 to 61 of 61 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: